The Precision Peptide Company Inc. (CSE:BPC)

CSE:BPC Cash Flow Statement

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Net Income	-5.73	-4.53	-1.03	-1.66	-1.13	-0.3
Depreciation & Amortization	0.09	0.09	0	0.01	0.04	0
Asset Writedown & Restructuring Costs	2.25	2.25	0.01	0.01	0.04	-
Stock-Based Compensation	0.77	-	0.11	0.35	0.08	-
Provision & Write-off of Bad Debts	-	-	0.03	0.03	-	-
Other Operating Activities	-0	-0	0.07	0.05	0	0.04
Change in Accounts Receivable	-0.04	-0.05	-0.01	0.05	-0.05	-0.14
Change in Inventory	-0.13	-0.07	-0.01	-0.02	-0.08	-0.05
Change in Accounts Payable	0.12	0.19	0.38	0.05	0.18	0.2
Change in Other Net Operating Assets	-0.06	-0.21	-0	0.16	0.21	-0.66
Operating Cash Flow	-2.73	-2.33	-0.44	-0.98	-0.72	-0.91
Capital Expenditures	-	-	-	-	-	-0.04
Cash Acquisitions	-0.2	-0.27	-	-	-	-
Sale (Purchase) of Intangibles	-	-	-	-	-0.01	-0.06
Investing Cash Flow	-0.2	-0.27	-	-	-0.01	-0.1
Short-Term Debt Issued	-	0.1	0.02	-	-	-
Total Debt Issued	0.1	0.1	0.02	-	-	-
Short-Term Debt Repaid	-	-0.12	-	-	-	-
Long-Term Debt Repaid	-	-	-	-	-0.05	-
Total Debt Repaid	-0.12	-0.12	-	-	-0.05	-
Net Debt Issued (Repaid)	-0.02	-0.02	0.02	-	-0.05	-
Issuance of Common Stock	0.47	0.71	0.51	0.99	0.05	2.4
Other Financing Activities	2.72	2.72	-	-0.03	-	-0
Financing Cash Flow	3.17	3.41	0.53	0.96	-0	2.4
Foreign Exchange Rate Adjustments	-0.04	0.02	-	-	-0	-
Net Cash Flow	0.2	0.82	0.09	-0.02	-0.73	1.38
Free Cash Flow	-2.73	-2.33	-0.44	-0.98	-0.72	-0.95
Free Cash Flow Margin	-2944.71%	-4694.10%	-3601.16%	-343.39%	-123.69%	-808.45%
Free Cash Flow Per Share	-0.09	-0.11	-0.07	-0.17	-0.16	-1.43
Levered Free Cash Flow	-1.86	-1.96	-0.06	-0.36	-0.21	-
Unlevered Free Cash Flow	-1.86	-1.96	-0.06	-0.36	-0.21	-
Change in Working Capital	-0.11	-0.14	0.37	0.24	0.26	-0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.